NIPS, a prenatal screening test based on cell free DNA technologies, has a high sensitivity and specificity for the detection of common fetal aneuploidies. However, these tests can also detect incidental findings. In rare cases, chromosomal abnormalities (typically more complex than seen in common fetal aneuploidy cases) can reflect changes in the mother s cells, such as maternal cancer, unrelated to the pregnancy. Currently, there are no professional recommendations to assist healthcare professionals regarding what to do if a NIPS result indicates potential risk for maternal cancer. An expert review has been published that provides a suggested approach to pretest counseling for a typical pregnant patient as well as next steps in case of a NIPS report suggestive of maternal cancer (Rink et al., Obstetrics and Gynecology, 2022)
- Provider:Postgraduate Institute for Medicine
- Activity Link: https://www.obgproject.com/2022/12/27/expert-commentary-on-the-incidental-detection-of-maternal-malignancies-via-prenatal-cell-free-dna-screening/
- Start Date: 2024-01-01 06:00:00
- End Date: 2024-01-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all